Z-0043-05
The MDA system with MDA Antithrombin III MDA Heparin
bioMerieux, Inc. / initiated 2004-06-11 / Terminated
bioMerieux began a recall of The MDA system with MDA Antithrombin III MDA Heparin on . The reason FDA records is "The firm received complaints regarding an observed bias in percent activity between capped and uncapped specimens". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-0043-05
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- bioMerieux, Inc.
- Product
- The MDA system with MDA Antithrombin III MDA Heparin
- Product code
- JPA System, Multipurpose For In Vitro Coagulation Studies
- Reason for recall
- The firm received complaints regarding an observed bias in percent activity between capped and uncapped specimens.
- FDA root cause
- Other
- Action
- Consignees were initially notified by letter on June 11, 2004. A follow up letter was sent to consignees, via Fedex on July 9, 2004.
- Distribution
- Nationwide, Australia, Belgium, Brazil, Canada, China, Germany, Italy, Japan, Taiwan, UK
- Product codes and lots
- All product numbers
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
